Ginkgo Bioworks Holdings, Inc. (DNA) vs MiMedx Group, Inc (MDXG)

Ginkgo Bioworks Holdings, Inc. and MiMedx Group, Inc are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and MiMedx Group, Inc are of similar size ($686.5M and $683.6M). Ginkgo Bioworks Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 117×. MiMedx Group, Inc grew revenue faster over the last twelve months: −2.36% against −37.0%. MiMedx Group, Inc has the higher net margin (1.76% vs −219.6%) and the higher return on invested capital (5.62% vs −161.9%). Across the 18 metrics below, MiMedx Group, Inc leads on 14 and Ginkgo Bioworks Holdings, Inc. on 4.

Valuation

Metric DNA MDXG Biotechnology median
P/E n/m 116.75 7.88
P/S 5.00 1.94 11.47
P/B 1.57 3.20 2.52
Price to free cash flow n/m 15.53 21.16
EV/EBITDA n/m 28.01 0.74
EV/Sales 5.77 1.61 10.73
Earnings yield (47.00%) 0.86% (28.84%)
Free cash flow yield (26.32%) 6.44% (23.03%)

Profitability

Metric DNA MDXG Biotechnology median
Gross margin 68.04% 78.85% 65.16%
Operating margin (231.13%) 2.46% 0.00%
Net margin (219.60%) 1.76% 0.00%
Free cash flow margin (131.57%) 12.51% 0.00%
Return on equity (56.29%) 2.88% (57.72%)
Return on assets (26.19%) 2.18% (49.22%)
Return on invested capital (161.94%) 5.62% 0.00%

Growth

Metric DNA MDXG Biotechnology median
Revenue growth (TTM) (37.02%) (2.36%) 5.64%
EPS growth (last fiscal year) 46.49% 14.29% —
Revenue growth, 5-year CAGR 17.29% 11.02% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNA MDXG Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 4.57 5.33 4.73
Net debt to EBITDA 1.63 (1.88) 0.96

Dividend

Metric DNA MDXG Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric DNA MDXG Biotechnology median
Market cap 683.64m 686.53m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack